Total Payments
$3,566
2024 Payments
$653.46
Companies
32
Transactions
181
Medicare Patients
19,377
Medicare Billing
$943,979
Payment Breakdown by Category
Food & Beverage$3,202 (89.8%)
Education$363.59 (10.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,202 | 175 | 89.8% |
| Education | $363.59 | 6 | 10.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,556 | 68 | $0 (2024) |
| Lilly USA, LLC | $379.45 | 27 | $0 (2024) |
| Astellas Pharma US Inc | $315.29 | 5 | $0 (2023) |
| Novo Nordisk Inc | $213.09 | 16 | $0 (2024) |
| Allergan, Inc. | $141.44 | 9 | $0 (2020) |
| Axsome Therapeutics, Inc. | $104.24 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $82.10 | 5 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $80.01 | 3 | $0 (2024) |
| PFIZER INC. | $61.08 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $59.38 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $653.46 | 37 | ABBVIE INC. ($183.32) |
| 2023 | $734.34 | 40 | ABBVIE INC. ($282.78) |
| 2022 | $697.14 | 30 | ABBVIE INC. ($600.56) |
| 2021 | $743.45 | 33 | AbbVie Inc. ($489.26) |
| 2020 | $237.24 | 16 | Allergan, Inc. ($141.44) |
| 2019 | $152.00 | 12 | Novo Nordisk Inc ($78.43) |
| 2018 | $241.94 | 6 | Astellas Pharma US Inc ($184.99) |
| 2017 | $106.32 | 7 | SANOFI-AVENTIS U.S. LLC ($35.29) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: ANTIBIOTIC | ||||||
| 10/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.46 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Education | In-kind items and services | $45.10 | General |
| Category: Narcoplepsy | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Obesity | ||||||
| 07/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $4.83 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/07/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Neurology | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: UROLOGY | ||||||
| 05/01/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $27.25 | General |
| Category: Neurology | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 04/15/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 4,744 | 6,752 | $332,794 | $231,581 |
| 2022 | 24 | 4,730 | 6,693 | $355,764 | $238,593 |
| 2021 | 25 | 4,876 | 6,942 | $346,014 | $242,788 |
| 2020 | 26 | 5,027 | 7,161 | $331,016 | $231,017 |
Total Patients
19,377
Total Services
27,548
Medicare Billing
$943,979
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 384 | 755 | $95,853 | $51,967 | 54.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 291 | 455 | $81,077 | $48,392 | 59.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 345 | 345 | $40,726 | $39,734 | 97.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 382 | 384 | $29,513 | $27,086 | 91.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 163 | 232 | $20,812 | $10,278 | 49.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 375 | 375 | $9,004 | $8,736 | 97.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 399 | 641 | $8,966 | $8,403 | 93.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 377 | 377 | $6,408 | $6,015 | 93.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 345 | 345 | $5,864 | $5,518 | 94.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 380 | 405 | $6,103 | $3,388 | 55.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 92 | 103 | $5,745 | $3,294 | 57.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 317 | 608 | $3,648 | $3,089 | 84.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 21 | 21 | $3,158 | $2,935 | 92.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 114 | 265 | $3,181 | $2,508 | 78.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 76 | 76 | $2,531 | $2,459 | 97.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 407 | 756 | $2,268 | $2,223 | 98.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 31 | 101 | $3,361 | $2,142 | 63.7% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 106 | 238 | $1,671 | $1,454 | 87.0% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2023 | 21 | 21 | $840.00 | $823.20 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 79 | $1,130 | $669.30 | 59.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 92 | 92 | $461.00 | $390.39 | 84.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 78 | $474.00 | $76.55 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 380 | 860 | $114,180 | $61,180 | 53.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 253 | 392 | $72,801 | $41,601 | 57.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 361 | 361 | $48,087 | $41,524 | 86.4% |
About Dr. Mark Mcnabb, D.O
Dr. Mark Mcnabb, D.O is a Internal Medicine healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942337522.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mcnabb, D.O has received a total of $3,566 in payments from pharmaceutical and medical device companies, with $653.46 received in 2024. These payments were reported across 181 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,202).
As a Medicare-enrolled provider, Mcnabb has provided services to 19,377 Medicare beneficiaries, totaling 27,548 services with total Medicare billing of $943,979. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cape Girardeau, MO
- Active Since 02/28/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942337522
Products in Payments
- UBRELVY (Drug) $1,303
- MOUNJARO (Drug) $350.61
- QULIPTA (Drug) $291.34
- Ozempic (Drug) $150.83
- Sunosi (Drug) $104.24
- VRAYLAR (Drug) $92.12
- Kerendia (Drug) $82.10
- WAKIX (Drug) $80.01
- NURTEC ODT (Drug) $56.44
- VOQUEZNA (Drug) $50.40
- GEMTESA (Drug) $49.48
- FARXIGA (Drug) $45.43
- LYRICA (Drug) $42.87
- BELSOMRA (Drug) $36.18
- SOLIQUA (Drug) $35.29
- QUVIVIQ (Drug) $32.70
- FreeStyle Libre 2 (Device) $32.53
- JARDIANCE (Drug) $28.84
- GVOKE HYPOPEN (Drug) $24.52
- Victoza (Drug) $22.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cape Girardeau
Dr. Daniel Lenihan, Md, MD
Internal Medicine — Payments: $120,661
Internal Medicine $120,661
Munis Raza, M.d, M.D
Internal Medicine — Payments: $15,330
Internal Medicine $15,330
Ira Taylor, Do, DO
Internal Medicine — Payments: $15,056
Internal Medicine $15,056
Dr. Chizor Iwuchukwu, M.d, M.D
Internal Medicine — Payments: $12,753
Internal Medicine $12,753
Dr. Steven Carr, Md, MD
Internal Medicine — Payments: $11,621
Internal Medicine $11,621
Nicholas Epstein
Internal Medicine — Payments: $3,732
Internal Medicine $3,732